Ah yes...the classic "I will gladly pay you Tuesda
Post# of 148277
We ALL want CYDY and leronlimab to succeed, but mistakes and inexperience are catching up with our CEO and our molecule.
I have not sold, will not sell, but to ignore the current situation is not a smart play either. What is a smart play? At this point, I don't know. I am willing to lose what I have put into this, and again remain hopeful that NASH results will be what we are hoping for, but even then, it may be too little too late.